Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral medicine for preventing and treating leukocytopenia caused by chemotherapy

A technology of medicine and traditional Chinese medicine, applied in the field of traditional Chinese medicine, can solve the problems of infection of blood-borne infectious diseases, short survival time, recurrence and growth of cancer, etc., and achieve the effect of low cost, not easy to fall back, and high efficiency

Active Publication Date: 2011-05-18
南通好又鲜水产食品有限公司
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Component blood transfusion, hematopoietic stem cell transplantation or support for severe bone marrow suppression, but there is a risk of infection of blood-borne infectious diseases, and the transfused blood cells have a short survival time due to rejection in the recipient and can promote cancer recurrence and growth possibility of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral medicine for preventing and treating leukocytopenia caused by chemotherapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Take the raw materials according to the following weight ratio:

[0031] Fairy Spleen 150g, Psoraleae 90g, Ligustrum lucidum 90g, Eclipta 90g, Caulis Spatholobus 150g, Polygonatum 150g, Astragalus 160g, Ginseng 90g, Poria cocos 100g, Atractylodes macrocephala 100g, Angelica 100g, Rehmannia glutinosa 100g, Rhizoma Chuanxiong 80g, Radix Paeoniae Rubra 80g, amomum 30g, donkey-hide gelatin 100g, roasted licorice 50g, gallinaceous gold 50g, fried malt 50g, tangerine peel 50g, pinellia 50g.

[0032] Preparation method: the above medicines are firstly crushed into coarse powder, and then made into 1000ml oral liquid through extraction, purification, concentration, sub-packaging, sterilization and other processes, 3 times a day, 20ml each time, for clinical application.

Embodiment 2

[0034] Take the raw materials according to the following weight ratio:

[0035] 3 parts of fairy spleen, 2 parts of psoralen, 3 parts of astragalus, 2 parts of raw ginseng, 2 parts of Atractylodes macrocephala, 2 parts of poria cocos, 2 parts of roasted licorice, 2 parts of angelica, 2 parts of Chuanxiong, 2 parts of red peony root, 2 parts of rehmannia glutinosa 2 parts of donkey-hide gelatin, 3 parts of Caulis Spatholobus, 3 parts of Polygonatum, 1 part of Chicken Negonia, 1 part of Fried Malt, 1 part of Pinellia, and 1 part of Tangerine Peel.

[0036] Production method: make the above-mentioned components into granules according to the production method of granules, 3 times a day, 9 grams each time, for clinical use.

Embodiment 3

[0038] 3 parts of fairy spleen, 2 parts of psoralen, 3 parts of astragalus, 2 parts of raw ginseng, 2 parts of Atractylodes macrocephala, 2 parts of poria cocos, 2 parts of roasted licorice, 2 parts of angelica, 2 parts of Chuanxiong, 2 parts of red peony root, 2 parts of rehmannia glutinosa 2 parts of donkey-hide gelatin, 3 parts of Caulis Spatholobus, 3 parts of Polygonatum, 1 part of Chicken Negonia, 1 part of Fried Malt, 1 part of Pinellia, and 1 part of Tangerine Peel.

[0039] Preparation method: make the above-mentioned components into liquid extract according to the preparation method of liquid extract, 3 times a day, 10 grams each time, for clinical use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oral medicine for preventing and treating leukocytopenia caused by chemotherapy, which is prepared from the following traditional Chinese medicines in parts by weight: 2-3 parts of herba epimedii, 1-2 parts of psoralea, 2-3 parts of astragalus root, 1-2 parts of sun-dried ginseng, 1-2 parts of bighead atractylodes rhizome, 2-3 parts of poria cocos, 1- 2 parts of prepared licorice, 1-2 parts of angelica, 1-2 parts of chuanxiong rhizome, 1-2 parts of red peony root, 1-2 parts of prepared rehmannia root, 1-2 parts of donkey-hide gelatin, 2-3 parts of spatholobus stem, -3 parts of rhizoma polygonati, 1-2 parts of chickens gizzard-membrane, 1-2 parts of fried malt, 1-1.5 parts of pinellia tuber and 1-1.5 parts of dried orange peel. The donkey-hide gelatin can be replaced by 0.5-1 part of antler glue. The oral medicine provided by the invention is a decoction, or can be prepared into an oral liquid, granules, a fluid extract or pill according to traditional methods. The oral medicine provided by the invention can be used for preventing and treating leukocytopenia caused by chemotherapy and can also be used for preventing and treating leukocytopenia caused by various other factors.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to an oral medicine suitable for preventing and treating leukopenia caused by chemotherapy. Background technique [0002] Radiotherapy and chemotherapy are two of the three major treatment methods for tumors. Both radiotherapy and chemotherapy can cause myelosuppression, especially chemotherapy is the most common. Clinically, leukopenia first appeared, which affected the smooth progress of chemotherapy, thereby affecting the curative effect of anti-tumor therapy. According to foreign literature reports, the treatment-related mortality rate related to IV degree myelosuppression hemogram in chemotherapy can reach 4%-21%. Clinically, the progress of chemotherapy is blocked due to cytopenia, which leads to a decrease in the efficacy of local tumor control, such as breast cancer, head and neck tumors, lung cancer and upper gastrointestinal tumors. Adverse reactions caused gr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8998A61P7/00A61K35/36A61K35/37A61K35/57
Inventor 耿平
Owner 南通好又鲜水产食品有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com